Cargando…

SMO Regulates IGF1R levels and AKT Localization and Signaling

The oncoprotein Smoothened (SMO), a Frizzled-class-G-protein-coupled receptor, is the central transducer of Hedgehog (Hh) signaling. While canonical SMO signaling is best understood in the context of cilia, evidence suggests that SMO has other functions in cancer biology that are unrelated to canoni...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Nitin K, Kim, Chae-Hwa, Kunkalla, Kranthi, Vaghefi, Amineh, Sanchez, Sandra, Manuel, Samantha, Bilbao, Daniel, Vega, Francisco, Landgraf, Ralf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8969180/
https://www.ncbi.nlm.nih.gov/pubmed/34893758
http://dx.doi.org/10.1038/s41374-021-00702-6
Descripción
Sumario:The oncoprotein Smoothened (SMO), a Frizzled-class-G-protein-coupled receptor, is the central transducer of Hedgehog (Hh) signaling. While canonical SMO signaling is best understood in the context of cilia, evidence suggests that SMO has other functions in cancer biology that are unrelated to canonical Hh signaling. Herein, we provided evidence that elevated levels of human SMO show a strong correlation with elevated levels of IGF1R and reduced survival in DLBCL. As an integral component of raft microdomains, SMO plays a fundamental role in maintaining the levels of IGF1R in lymphoma and breast cancer cells as well IGF1R associated activation of AKT. Silencing of SMO increases lysosomal degradation and favors a localization of IGF1R to late endosomal compartments instead of early endosomal compartments from which much of the receptor would normally recycle. In addition, loss of SMO interferes with the lipid raft localization and retention of the remaining IGF1R and AKT, thereby disrupting the primary signaling context for IGF1R/AKT. This activity of SMO is independent of its canonical signaling and represents a novel and clinically relevant contribution to signaling by the highly oncogenic IGF1R/AKT signaling axis.